French Firm Stilla Technologies, which last year launched a novel dropletbased digital PCR system with a singular three-color multiplexing capability, is now supplying its systems worldwide the company said this week. According to the firm’s President and Founder Rémi Dangla, Stilla is seeing two main types of customers for its Crystal Digital PCR: newcomers, who are new to digital PCR but are familiar with quantitative approaches and appreciate that Stilla’s platform offers similar usability and time to results as other systems; and digital PCR experts, who have other systems in place already but have decided they need more multiplexing capability.

Source : Genomeweb

>> Read full article